December 27 was the 100th birthday of pathologist Jan Steiner, MD, FRCP (C), FCAP, remembered by many long-serving lab executives and clinical pathologists as one of the co-founders, along with James Root, PhD, of Chi Laboratory Systems in the late 1980s. This was a time when he was already in his 70s. He worked with Chi and its successor company, PCS Solutions, into his 90s. Steiner was always known for his high energy and his dynamic presentations at lab conferences. He is reported to be healthy and happy in retirement in Michigan.
MORE ON: Dr. Steiner
Born in Czechoslovakia, Steiner trained in Prague, Liverpool, and Oxford. He survived World War II and found his way to Canada. He was senior pathologist at Toronto General Hospital for 20 years. Upon arriving in the United States, Steiner became Director of the Illinois Comprehensive Cancer Center, under the aegis of the National Cancer Institute. Steiner authored more than 200 scientific papers. In 1982, Steiner became the Medical Director for the U.S. operations of MDS Health Group. In 1985, he joined Chi Systems of Ann Arbor, Mich. Within a few years, Steiner and Root spun off the lab consulting business of Chi to form Chi Laboratory Systems.
FEDS INDICT DOC IN NJ BDL CASE
Another physician has been indicted in the federal case of fraud and abuse involving the now-defunct Biodiagnostic Laboratory Services (BLS) of Parsippany, NJ. Internist Thomas Savino, MD, of Staten Island, NY, faces multiple counts, including conspiracy. He is accused of accepting $25,000 in bribes in exchange for making lab test referrals worth $325,000 to BLS.
- Cynthia Collins will assume duties as CEO of Human Longevity, Inc., of San Diego, allowing founder and current CEO Craig Ventor, PhD, to be Executive Chairman of HLI’s Board of Directors. Collins held leadership positions at GE Healthcare, Clarient Diagnostics GenVec, Beckman Coulter, GenMarkDiagnostics, Baxter Healthcare, and Abbott Laboratories.
- Illumina named Jonathan Seaton as its new Senior Vice President for Corporate and Business Development. Seaton previously held executive positions at BD, Roche Diagnostics, Roche Tissue Diagnostics, LS9, and Deutsche Bank.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…the intriguing findings of a study published in JAMA that indicates that being a “second user” of a bed previously used by a patient taking antibiotics may be another risk factor for acquiring Clostridium difficile.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, January 30, 2017.